Core Viewpoint - The brain-computer interface (BCI) sector is experiencing a surge in interest and investment following Elon Musk's announcement of mass production plans for BCI devices by Neuralink in 2026, leading to significant stock price increases in related companies [1][2][3] Market Reaction - On January 5, the A-share BCI sector index rose by 13.7% to 1861.12 points, and on January 6, it opened at 1956.76 points, peaking at 1973.98 points, closing at 1967.92 points, resulting in a cumulative increase of 20.22% over two trading days [1][2] - 19 concept stocks experienced consecutive trading halts, with notable gains such as Beiyikang, which saw a cumulative increase of 69.95%, reaching 58.44 yuan per share [2] Industry Growth Potential - The global BCI market is projected to reach approximately $2.6 billion in 2024, with China's market expected to be around 3.2 billion yuan; by 2034, the global market is anticipated to grow to about $12.4 billion [3] - The BCI industry is expected to see an annual growth rate of around 20% in China from 2024 to 2028, significantly outpacing traditional manufacturing sectors [3] Policy and Technological Support - The Chinese government has set clear development goals for the BCI industry through policies issued by multiple departments, aiming to promote innovation and application across various sectors beyond medical rehabilitation [4][5] - The introduction of separate billing for BCI projects by the National Healthcare Security Administration addresses key payment issues, facilitating industry development [4] Competitive Landscape - China is positioned in the leading tier of global BCI research, with over 800 core enterprises in the BCI industry chain, primarily located in the U.S. and China [5] - The market is seeing a mix of invasive and non-invasive technologies, with successful clinical trials for invasive BCIs marking significant progress in the field [5] Investment Trends - Investment enthusiasm in the BCI sector is rising, with 14 financing events in the first half of 2025, totaling over 800 million yuan, and BCI being the most popular segment, accounting for 43% of the financing [6] - From January to November 2025, there were 24 financing deals in the BCI field, reflecting a 30% year-on-year increase, indicating strong investor interest [6]

Group 1: Commercial Aerospace - China Aerospace Science and Technology Corporation's commercial rocket subsidiary increased its registered capital from 1 billion to 1.396 billion yuan, with a 77.6% increase in investment from the parent company [5] - Blue Arrow Aerospace is aiming to become the first publicly listed commercial rocket company, with the commercial aerospace sector expected to enter a golden development period [9] - The low-orbit satellite internet in China is set to enter mass launch construction in the second half of 2025, with significant acceleration in industry development anticipated by 2026 [11] Group 2: Brain-Computer Interface - The first fully implanted, wireless, and fully functional brain-computer interface product in China has successfully completed its first clinical trial [20] - The brain-computer interface industry is expected to reach a market size of over 10 billion USD by 2030, with companies like Haige Communication and Xiangyu Medical seeing significant stock price increases [22] - Xiangyu Medical is focusing on non-invasive rehabilitation and exploring invasive technologies, with plans to cover over 1,000 top-tier hospitals by 2026 [24] Group 3: Financial Sector - The National Financial Regulatory Administration has lowered risk factors for long-term holding assets, which is expected to cultivate patient capital and support technological innovation [30] - The financial sector is experiencing strong performance, with stocks like Zhina Compass seeing a significant increase in value due to market expectations of a bull market [31] Group 4: Intelligent Driving - Nvidia plans to test a driverless taxi service by 2027, indicating advancements in autonomous driving technology [33] - The first batch of L3 autonomous vehicles in China has begun large-scale road operation, with companies like Wanjite Technology benefiting from this trend [34] - The automatic driving technology is moving towards mass production applications, with companies like Haoen Automotive seeing stock price increases [36]

Group 1 - The core viewpoint of the article is the successful launch of the Fudan Innovation Investment Fund, which has completed its private fund product filing and is now operational [1] - The total scale of the Fudan Innovation Investment Fund is 1 billion yuan, co-founded by Fudan Innovation Mother Fund, Shanghai Future Industry Fund, and Jing'an Capital, with additional investors including Zhejiang Longsheng Group and Anhui Jinbiandan Equity Investment [1] - The fund will focus on strategic emerging industries such as life health, artificial intelligence, integrated circuits, new energy, and new materials, as well as future industries like quantum technology, biomanufacturing, hydrogen energy, nuclear fusion energy, brain-computer interfaces, embodied intelligence, and sixth-generation mobile communication [1]

以下文章来源于公募排排网 ，作者排排产品研究中心 公募排排网 . 看财经、查排名、买基金，就上公募排排网，申购费低至0.001折。 本文首发于公众号"公募排排网"。（点击↑↑上图查看详情） 2026年首个交易日，A股迎来"开门红" 2026年首个交易日，A股迎来"开门红"。 在节前上涨趋势延续的背景下，三大指数高开高走， 上证指数盘中重返4000点， 节前积累的风险偏 好在节后集中释放，市场情绪明显修复。 从结构看，科技与成长板块成为主要做多力量。 AI、半导体、脑机接口等科技与新兴产业板块表现突出，多只核心标的涨停或领涨，对指数形成显著拉动效应，也进一步强化了市场对中长期产 业趋势的定价。 资金层面，人民币汇率企稳回升提供边际支撑。 近期人民币对美元汇率呈现稳中有升态势，在岸汇率一度回到6.98区间下方，有助于改善跨境资金预期，提升以人民币计价资产的相对吸引力， 为外资回流与流动性修复创造有利环境。 外部环境方面，港股与海外市场形成正向联动。 一是科技成长方向， 包括人工智能全产业链，以及半导体设备、材料等国产替代环节； 二是先进制造领域， 关注储能、光伏出海及新能源汽车智能驾驶渗透率提升； 三是顺周期与消 ...

智通财经APP讯，亚辉龙(688575.SH)发布公告，公司于近日与深圳脑机星链科技有限公司(简称："脑机 星链")签署了《战略合作框架协议》，双方共同达成战略合作，通过整合脑机接口技术与临床和市场资 源，共同开发脑机接口相关在研产品及推进后续市场拓展及推广，提升在中枢神经疾病等领域诊疗技术 水平。 本次战略合作，将结合双方的优势，有利于提升公司在中枢神经疾病等领域竞争力以及拓展公司在脑机 接口相关领域的战略布局，符合公司长远发展战略和全体股东的利益。 脑机星链是一家以人工智能为核心驱动力，深耕非侵入式与侵入式双技术路径，致力于构建"基础研究- 技术转化-产业落地"全链条发展体系并成为脑机接口领域领先企业，通过脑机接口应用平台(神经解码 软件、超柔性多通道电极、应用芯片)与神经调控技术深度结合，加速阿尔茨海默症、孤独症、抑郁 症、脑疾病神经类疾病检测与诊断产品落地，形成横跨硬件终端、算法模型与云端服务的三位一体架 构。目前已开发有脑电采集分析仪、脑机接口助眠仪、脑机接口睡眠监测仪、迷走神机刺激仪等产品。 ...

脑机星链是一家以人工智能为核心驱动力，深耕非侵入式与侵入式双技术路径，致力于构建"基础研究- 技术转化-产业落地"全链条发展体系并成为脑机接口领域领先企业，通过脑机接口应用平台(神经解码 软件、超柔性多通道电极、应用芯片)与神经调控技术深度结合，加速阿尔茨海默症、孤独症、抑郁 症、脑疾病神经类疾病检测与诊断产品落地，形成横跨硬件终端、算法模型与云端服务的三位一体架 构。目前已开发有脑电采集分析仪、脑机接口助眠仪、脑机接口睡眠监测仪、迷走神机刺激仪等产品。 本次战略合作，将结合双方的优势，有利于提升公司在中枢神经疾病等领域竞争力以及拓展公司在脑机 接口相关领域的战略布局，符合公司长远发展战略和全体股东的利益。 格隆汇1月6日丨亚辉龙(688575.SH)公布，亚辉龙于近日与深圳脑机星链科技有限公司签署了《战略合 作框架协议》。 ...

2026年首个交易日，A股市场迎来"开门红"，上证指数重新站上4000点。1月6日，上证指数又走出13连 阳的新纪录，报收4083.67点，再创十年新高；两市及北交所共4101只股票上涨。 从板块来看，脑机接口概念延续强势，十余只成分股涨停，三博脑科、美好医疗、创新医疗2连板。被 视为"牛市旗手"或"市场风向标"的券商股强劲上行，华林证券冲上涨停，华安证券、东北证券等多股大 涨。有色金属板块表现活跃，洛阳钼业、紫金矿业等多股创历史新高。商业航天概念反复活跃。 这种从"模式创新"向"底层技术创新"的偏好反转，体现了投资者对中国经济高质量发展的坚定信心。科 技不再是市场的点缀，而是成为了定盘星，重构了资本市场的估值体系与成长逻辑。 与此同时，作为"牛市旗手"的券商股与作为"价值压舱石"的有色金属板块交相辉映，构成了市场上涨的 双翼。券商股的爆发，折射出市场信心的全面修复以及对资本市场制度改革红利的预期；而洛阳钼业、 紫金矿业等资源巨头创下历史新高，则反映了在全球通胀预期与工业硬需求下，中国核心资产在全球配 置中的独特性与稀缺性。 这种"科技领航、金融助攻、资源筑底"的良性互动，标志着市场进入了一个更加成熟、更加均 ...

格隆汇1月6日｜据澎湃，近期脑机接口"独角兽"强脑科技完成约20亿元融资，为脑机接口领域除马斯克 旗下Neuralink以外世界第二大规模融资。据悉，投资人阵容强大，包括著名投资机构IDG、由英特尔 CEO陈立武创立的华登国际，"果链"巨头蓝思科技、领益智造，战略投资方韦尔股份、润泽科技、华住 集团、好未来集团，也有中国香港、美国顶级家办等。 强脑科技与DeepSeek，宇树科技，黑神话悟空 等科技企业并称为"杭州六小龙"，专注脑机接口领域产品研发，目前已经获得美国FDA认证，欧洲CE 认证，为世界脑机接口领域的研发投入最大的企业之一，产品曾获《时代》周刊，年度最佳发明，是全 球极其少数实现脑机接口产品规模性量产的企业。 ...

智通财经1月6日讯，今日120股涨停，25股炸板，封板率为83%，胜通能源13连板，锋龙股份8连板，雷 科防务5连板，友邦吊顶、南兴股份4连板，索菱股份、城建发展、农心科技3连板，嘉美包装16天12 板，浙江世宝14天7板，鲁信创投8天6板，北斗星通10天5板，中国卫通6天4板。三大指数集体收涨，沪 指高开高走，日线录得13连阳，再创十年新高。量能持续放大，沪深两市成交额2.81万亿，较上一个交 易日放量2602亿。板块方面，脑机接口、化工、有色金属板块涨幅居前；美容护理、CPO、银行板块表 现相对落后。 人气及连板股分析 连板晋级率升至71.42%，其中3板及以上连板股全部实现晋级，随着人气龙头胜通能源复牌缩量涨停晋 级13连板，高位股情绪得到逆转并重新获得资金聚焦，嘉美包装、鹭燕医药、国晟科技、浙江世宝等多 只人气品种封涨停，进而带动商业航天、机器人、脑机等近端主线热度持续提升，其中20、30厘米弹性 票的赚钱效应依旧居高不下，合计涨停家数维持20家左右的高位。不过近期高弹性票的强度，仍基于几 大热门板块内10厘米人气股的不断向上拓展空间，一旦其中部分品种出现掉队，仍不利于其赚钱效应维 持高位。 | 连板 ...

Core Viewpoint - The A-share market saw a collective rise in its three major indices, with the Shanghai Composite Index reaching a ten-year high, driven by strong performance in the brain-computer interface sector [1] Group 1: Market Performance - On January 6, the A-share market indices collectively rose, with the Shanghai Composite Index opening high and continuing to climb [1] - The brain-computer interface concept stocks maintained strong momentum, with companies like Beikang and Sanbo Brain Science hitting their daily price limits [1] Group 2: Company Developments - Elon Musk announced via social media that his company Neuralink plans to start large-scale production of brain-computer interface devices by December 31, 2026, and will advance nearly fully automated surgical procedures [1] - Merge Labs, a startup co-founded by OpenAI CEO Sam Altman, announced its spin-off to focus on non-invasive brain signal reading technology using ultrasound, aiming for broader and more precise interpretation without electrode implantation [1] Group 3: Industry Insights - According to a report by Guokai Securities, brain-computer interfaces are at the forefront of artificial intelligence technology and are expected to accelerate applications in medical, mental health, rehabilitation, and health management sectors with policy support [1] - Since 2025, both domestic and international AI technologies, products, and commercial applications have rapidly developed, with the pharmaceutical industry being a key application area, indicating significant potential for AI in drug development, auxiliary diagnosis, and services [1]